ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 06 Feb 2023
Last Applicant/ Owned by
3545 Cray Court
San Diego
CA
92121
Serial Number
90238399 filed on 06th Oct 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
KRASLOQ
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Class [005]
Pharmaceutical Products
pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
Mark Details
Serial Number
No 90238399
Mark Type
No Service Mark
Attorney Docket Number
No MBHB 20-1657
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Feb 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 06th Feb 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 02th Jul 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Jun 2022 | SOU TEAS EXTENSION RECEIVED |
| 30th Jun 2022 | SOU EXTENSION 1 FILED |
| 30th Jun 2022 | SOU EXTENSION 1 GRANTED |
| 04th Jan 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 09th Nov 2021 | PUBLISHED FOR OPPOSITION |
| 09th Nov 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Oct 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |